Form 6-K TARO PHARMACEUTICAL INDU For: Nov 03
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Taro Pharma (TARO) Reports Q2 EPS of $3.11
November 4, 2015 7:16 AM ESTTaro Pharma (NYSE: TARO) reported Q2 EPS of $3.11, versus $3.35 reported last year. Revenue for the quarter came in at $212.1 million, versus $250.8 million reported last year.
For earnings history and earnings-related data on Taro Pharma (TARO) click here.
... More